Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Fowler

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 12, 2011
Later outcomes and alpha/beta estimate from hypofractionated conformal three-dimensional radiotherapy versus standard fractionation for localized prostate cancerFelix Leborgne, Jack Fowler, José H Leborgne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2010
A "Red Shell" concept of increased radiation damage hazard to normal tissues just outside the PTV target volumeJack Fowler, Jun Yang, John Lamond, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2012
Effect of fractionation in stereotactic body radiation therapy using the linear quadratic modelJun Yang, John Lamond, Jack Fowler, et al.
International Journal of Radiation Oncology, Biology, Physics|January 22, 2013
Revising the radiobiological model of synchronous chemotherapy in head-and-neck cancer: a new analysis examining reduced weighting of accelerated repopulationSara Meade, Paul Sanghera, Christopher McConkey, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2002
How fast is repopulation of tumor cells during the treatment gap?Rafal Tarnawski, Jack Fowler, Krzysztof Skladowski, et al.
International Journal of Radiation Oncology, Biology, Physics|May 8, 2010
Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancerGiorgio Arcangeli, Jack Fowler, Sara Gomellini, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trialEric E Yeoh, Rochelle J Botten, Julie Butters, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2010
Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapyShreerang A Bhide, Sarah Gulliford, Jack Fowler, et al.
Biomed Research International|December 19, 2013
What would be the most appropriate α/β ratio in the setting of stereotactic body radiation therapy for early stage non-small cell lung cancerAlexander Chi, Sijin Wen, Zhongxing Liao, et al.
American Journal of Clinical Oncology|June 12, 2010
Stereotactic body radiation therapy in non-small-cell lung cancer: linking radiobiological modeling and clinical outcomeAlexander Chi, Wolfgang A Tomé, Jack Fowler, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|April 12, 2011
Later outcomes and alpha/beta estimate from hypofractionated conformal three-dimensional radiotherapy versus standard fractionation for localized prostate cancerFelix Leborgne, Jack Fowler, José H Leborgne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2010
A "Red Shell" concept of increased radiation damage hazard to normal tissues just outside the PTV target volumeJack Fowler, Jun Yang, John Lamond, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2012
Effect of fractionation in stereotactic body radiation therapy using the linear quadratic modelJun Yang, John Lamond, Jack Fowler, et al.
International Journal of Radiation Oncology, Biology, Physics|January 22, 2013
Revising the radiobiological model of synchronous chemotherapy in head-and-neck cancer: a new analysis examining reduced weighting of accelerated repopulationSara Meade, Paul Sanghera, Christopher McConkey, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2002
How fast is repopulation of tumor cells during the treatment gap?Rafal Tarnawski, Jack Fowler, Krzysztof Skladowski, et al.
International Journal of Radiation Oncology, Biology, Physics|May 8, 2010
Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancerGiorgio Arcangeli, Jack Fowler, Sara Gomellini, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trialEric E Yeoh, Rochelle J Botten, Julie Butters, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2010
Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapyShreerang A Bhide, Sarah Gulliford, Jack Fowler, et al.
Biomed Research International|December 19, 2013
What would be the most appropriate α/β ratio in the setting of stereotactic body radiation therapy for early stage non-small cell lung cancerAlexander Chi, Sijin Wen, Zhongxing Liao, et al.
American Journal of Clinical Oncology|June 12, 2010
Stereotactic body radiation therapy in non-small-cell lung cancer: linking radiobiological modeling and clinical outcomeAlexander Chi, Wolfgang A Tomé, Jack Fowler, et al.
Pageof 4